FDA-approvedMelanocortin agonistSexual desire (women)
PT-141 (bremelanotide)
PT-141 (bremelanotide) is a melanocortin-receptor agonist, FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.
What is PT-141?
PT-141 (bremelanotide) is a melanocortin-receptor agonist, FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.
Key takeaways
- PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.
- PubMed indexes 95 papers on PT-141 (11 tagged as clinical trials) as of October 19, 2026.
- ClinicalTrials.gov lists 10 registered studies using PT-141.
- 39 vendors in our directory listed PT-141 in their public catalog on October 19, 2026.
Structure
Regulatory & access status
PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.
- VYLEESI (AUTOINJECTOR) — COSETTE, application NDA210557 (prescription). Drugs@FDA
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on PT-141 (bremelanotide)?
PubMed indexes 95 papers mentioning PT-141 (bremelanotide) in the title or abstract, 52 of them from the last five years and 11 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Bremelanotide. — , 2012 · review
- Bremelanotide. — , 2006 · review
- Bremelanotide: First Approval. — Drugs, 2019 · review
- Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. — J Midwifery Womens Health, 2021 · review
- Bremelanotide for Treatment of Female Hypoactive Sexual Desire. — Neurol Int, 2022 · review
- Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder. — Ann Pharmacother, 2020 · review
Registered clinical studies
ClinicalTrials.gov lists 10 studies with PT-141 (bremelanotide) as an intervention (see all). Most recent:
- Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder — NCT04179734 · Phase 4 · completed · started 2019-10-07
- A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity — NCT06565611 · Phase 2 · active not recruiting · started 2024-08-05
- 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder — NCT02338960 · Phase 3 · completed · started 2015-01
- A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal) — NCT04943068 · Phase 3 · completed · started 2021-05-10
- Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder — NCT01382719 · Phase 2 · completed · started 2011-06
What the evidence does not show
- Paper counts measure research attention, not whether PT-141 works or is safe.
Research suppliers that list PT-141
39 vendors in our directory listed a product matching PT-141 in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- Amino Amigos
- Ascension Peptides
- Atomik Labz
- Backroad Aminos
- Biocollex Research
- BioGenix Peptides
- Biotech Peptides
- Bulk Peptide Supply
- Core Peptides
- Dynamic Peptide
- Eros Peptides
- Evolve BioPep
- Extreme Peptides
- Ion Peptide
- Liberty Peptides
- Licensed Peptides
- LotusPeptide
- Modern Aminos
- Paramount Peptides
- Peptide Crafters
- Peptide Partners
- Peptide Worldwide
- Peptide.Express
- Pharma Grade Peptides
- Plum Labs Research
- Polaris Peptides
- Prime Lab Peptides
- ProtideHealth
- Pure Lab Peptides
- Ramp Peptides
- Royal Peptides
- San Diego Peptides
- Science.bio
- Southern Aminos
- Sports Technology Labs
- Sunrise BioResearch
- Swiss Chems
- Verified Peptides
- Voltera Sciences
Prices per mg, where we could verify them, are on our price comparison.
PT-141 reconstitution math
Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.
PT-141 FAQ
Is PT-141 FDA-approved?
PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.
Is PT-141 safe?
Safety data come from the published studies listed on this page; read them in full. Products sold as "research use only" have no FDA review of their purity, sterility or dose.
How much research is there on PT-141?
PubMed indexes 95 papers on PT-141 (11 tagged as clinical trials) as of October 19, 2026.
Who sells PT-141?
Amino Amigos, Ascension Peptides, Atomik Labz, Backroad Aminos, Biocollex Research, BioGenix Peptides and 33 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Head-to-head comparisons
Related compounds
OxytocinhCGTriptorelinKisspeptin-10GonadorelinMelanotan IIhMGProstamaxAll sexual & reproductive health